Alpha-synucleïnemonoklonale antilichamen, cy5.5 Vervoeging

May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.

Alpha synuclein; Alpha-synuclein, isoform NACP140; alpha SYN; MGC105443; MGC110988; MGC127560; MGC64356; NACP; Non A beta component of AD amyloid; Non A4 component of amyloid precursor; Non-A-beta component of alzheimers disease amyloid , precursor of; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; PARK 1; PARK 4; PARK1; PARK4; Parkinson disease (autosomal dominant, Lewy body) 4; Parkinson disease familial 1; PD 1; PD1; Syn; SNCA; Snca synuclein, alpha (non A4 component of amyloid precursor) ; SYUA_HUMAN; Synuclein alpha; Synuclein, alpha (non A4 component of amyloid precursor)

6622

P37840

Cytoplasm, Nucleus, Cell membrane

Human

Alpha-Synuclein

7B7

Cy5.5

KLH conjugated synthetic peptide derived from human Alpha-Synuclein

IF

Purified by Protein G.

675nm/694nm

1µg/µl

IF ()

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

6622